Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Vestal Point Capital, LP's stake in Kalvista Pharmaceuticals, Inc. fell to 1.50% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Vestal Point Capital, LP's stake in Kalvista Pharmaceuticals, Inc. fell to 1.50%, 750,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 1.50%
- Shares
- 750,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 1.50% | 750,000 |
| Ryan Wilder | 1.50% | 750,000 |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Vestal Point Capital, LP
- Kalvista Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026